Because mutant TP53 was associated with a high 21-gene RS in the subset with good pathological features, we investigated the molecular characteristics of mutated TP53 in ER+/PR+/HER2−, stage I/II BC tumors using TCGA database. This evidence concerns the gene ESR1 and breast cancer.